All News #Library
Others
GeNeuro Announces Recruitment of Patient in Centers in Trial Assessing Temelimab
16 Nov 2022 //
BUSINESSWIRE
Geneuro Receives CHF 6.7M in Funding to Develop Temelimab Against Long-COVID
13 Dec 2021 //
BUSINESSWIRE
GeNeuro announces agreement to assess W-ENV and long-Covid syndromes
27 Sep 2021 //
PHARMACEUTICAL-TECHNOLOGY
GeNeuro and Northwestern University Collaborate on HERV-W ENV in Long-haul COVID
24 Sep 2021 //
BUSINESSWIRE
How GeNeuro`s experimental MS drug might help treat COVID-19
15 Apr 2021 //
FIERCEBIOTECH

Market Place
Sourcing Support